Editorial Shares Takeaways from Recent Deprescribing Study
The DCRI’s Eric Peterson, MD, MHS, recently reviewed an important study in JAMA examining novel strategies to de-escalate hypertension treatment in older adults.
DCRI Studies Lead To Greater Knowledge about Video Gaming as an ADHD Treatment
In a first-of-its-kind decision, the FDA has approved a video game as a prescribed treatment for children with ADHD.
Hernandez Talks HCQ Retractions, HERO Research
The Rise of Telehealth During COVID-19
PTN, CTTI Partner on Study, Identify Risk Factors for Hospital-Acquired Pneumonia
The study team used pediatric patients’ electronic health records to identify patients eligible for the study.
DCRI Cardiologists Help to Define Care Pathway for Patients with COVID-19
In response to a wide array of cardiovascular complications seen in patients with COVID-19, the Duke Health system has developed a framework which organizes its approach to caring for patients with
DCRI to Partner with Boehringer Ingelheim and Eli Lilly on new Pragmatic Trial
The indication-seeking trial is the first in the SGLT2 inhibitor class to investigate whether empagliflozin can be used to prevent heart failure after a heart attack.
IPF-PRO Registry Continues to Shed Light on Devastating Lung Disease
The registry, which has enrolled 1,002 patients with idiopathic pulmonary fibrosis, shares critical knowledge and insights to help combat lung disease.
Pediatric Trials Network Research Contributes to Three Recent Drug Label Changes
Data provided to the FDA by the research network has helped to provide a fuller picture for prescribing these medications to pediatric populations.
Novel Micra Pacemaker Found to Reduce Patient Risk
A pragmatic comparative effectiveness study comparing Micra leadless pacemakers to conventional transvenous pacemakers found that for patients who received the novel leadless pacemakers, complicati